Trial Outcomes & Findings for Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap (NCT NCT01684839)

NCT ID: NCT01684839

Last Updated: 2024-02-15

Results Overview

The Static 2-point Discrimination Test determined the minimal distance at which a subject can sense the presence of two needles. The modified American Society for Surgery of the Hand guidelines was used to stratify the 2PD measurements (excellent \<6 mm; good 6-10 mm; fair 11-15 mm; poor \>15 mm). The test points were at the center of the radial or ulnar portion of the finger pulp (i.e., injury side). Each area was tested 3 times with a discriminator (Ali Med, Dedham, MA). Two out of 3 correct answers were considered proof of perception before proceeding to another lower value. We stopped at 4mm as a limit of 2PD and consider this normal. The measurements were performed at a single time point at the final follow up.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

9 participants

Primary outcome timeframe

20-26 months postoperatively

Results posted on

2024-02-15

Participant Flow

Nine patients were included in the study. These patients were treated with the pedicled nerve flap. The type of location was medical clinic.

No wash out, run-in or transition happened in the study.

Participant milestones

Participant milestones
Measure
New Surgical Treatment
Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap taken from the homolateral dorsal branch of the digital nerve.
Overall Study
STARTED
9
Overall Study
COMPLETED
9
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
New Surgical Treatment
n=9 Participants
Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap taken from the homolateral dorsal branch of the digital nerve.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
31.4 years
STANDARD_DEVIATION 7.3 • n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
Region of Enrollment
China
9 participants
n=5 Participants

PRIMARY outcome

Timeframe: 20-26 months postoperatively

The Static 2-point Discrimination Test determined the minimal distance at which a subject can sense the presence of two needles. The modified American Society for Surgery of the Hand guidelines was used to stratify the 2PD measurements (excellent \<6 mm; good 6-10 mm; fair 11-15 mm; poor \>15 mm). The test points were at the center of the radial or ulnar portion of the finger pulp (i.e., injury side). Each area was tested 3 times with a discriminator (Ali Med, Dedham, MA). Two out of 3 correct answers were considered proof of perception before proceeding to another lower value. We stopped at 4mm as a limit of 2PD and consider this normal. The measurements were performed at a single time point at the final follow up.

Outcome measures

Outcome measures
Measure
New Surgical Treatment
n=9 Participants
Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap taken from the homolateral dorsal branch of the digital nerve.
Static 2-point Discrimination Test
7.3 mm
Standard Deviation 2.0

SECONDARY outcome

Timeframe: 20-26 months postoperatively

The maximum score was 100 and was grouped into 4 ranges (0-25; 26-50; 51-75; and 76-100), corresponding to mild, moderate, severe, and extreme severity, respectively.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 20-26 months postoperatively

Tinel's sign was graded as the following: grade 1=none; grade 2=mild, slight tingle; grade 3=moderate, very uncomfortable; and grade 4=severe, patient unable to use hand because of any stimulation of the neuroma

Outcome measures

Outcome data not reported

Adverse Events

New Surgical Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Chao Chen

The Second Hospital of Tangshan

Phone: 86-13700350471

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place